$MDT Medtronic Tape Reports
Per Ticker.id: $MDT Medtronic Tape Reports — 7 podcast mentions across 1 podcast (30 days), latest 2026-08-14 00:03 UTC.
Negotiate aggressively, ask for concessions on closing costs, on rate buydowns, on repairs. Don't wait for a 2008-style crash that is not coming. The structural supply shortage in most markets will not allow it. But don't overpay either. In the 38 markets where the sale-to-list ratio is below 100%, time is on your side. Use it. Now, from time to time, we also receive questions via web form from investtalk.com, and here's one that came in from our friend Randall on ticker PLSE. Let's type this in, then I'll read the question. And it says, I have a fairly large position, 3,250 shares, in a company called Pulse Biosciences, ticker PLSE, I have held this stock through a long downturn and trimmed some of the shares in the upswing we had recently. The question is, should I continue to hold, continue to trim, buy more, or get out? It is about 3% of my total portfolio. So before looking at all this, 3% is a perfectly reasonable allocation, uh, of your overall total portfolio to any single stock. So without even looking at it, the, the fact that you have 3% doesn't mean, okay, I need to trim. Now let's dive into this company specifically. PLSE, as I mentioned, is Pulse Biosciences. So they are a bioelectric medicine company. They have nanopulse stimulation, they have ablation technology as well. And so their big thing is this N-Pulse cardiac catheter system for atrial fibrillation, atrial fibrillation, afib. All right, um, that's a huge growing area for a lot of these med tech companies. Abbott has a big division that deals with the catheters, Medtronic, Bicentis Webster, Johnson Johnson. So this falls in, in the category there. Now this company is roughly $3 billion, so a bit of a small cap company revenue, kind of all over the place. $1.4 billion in 2021, $700 million in 2022, zero the next two years, $350 million in '25, projected to be $2.44 billion this year. They haven't made really any money. Their net margin has always been negative. Return on assets, return on equity has been negative. Pretty volatile. I mean, it topped out at $44.15 back in 2020, then it dropped off a cliff to about $1, uh, and since 2022 it has been climbing in a not peaceful way, uh, back up to $44.92, uh, where it's trading today.
Luke Guerrero — InvestTalk · U.S. Housing Market Cracks: Homes Selling Below Asking Price in 38 Major Cities · 2026-08-14